Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

NCT00985855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG: cisplatin, vinorlebine, cetuximab
DRUG: cisplatine, etoposide, cetuximab

Sponsor

Institut de Cancérologie de la Loire